Wednesday, 8 April 2026
- Easy Return Policy: 10 Days Read More
- Best Selling Items: Up to 60% Off View More
- Delivery Method: All India Delivery (1.55 Lakhs Pincode) TC
- Customer Support: Raise 24*7 Quick Complaint
- Use Coupon: Get 50% Off (Follow us on Facebook). View Offers
- Save More: Up to 30% off on Shipping Above ₹559* View Offers
- COD: Subscription: Rs.999 Yearly!. T/C Apply
Frequently bought together
Our Recommendations!
Snatch up these popular items our customers love, bundled together for the best deal you'll find anywhere. Don't miss out on scoring big with this unbeatable offer!
Anticancer Activity in Heterocyclic Organic Structures A Pathway to Novel Drug Development | Mchichi L E | Latest Edition | Taylor & Francis Group (English)
|
|
| 19736-19736 |
"Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development" is a groundbreaking book that explores the potential of heterocyclic organic structures in developing novel drugs for cancer treatment. Authored by Mchichi L E, this latest edition published by Taylor & Francis Group delves into the various aspects of anticancer activity and drug development, making it an essential read for researchers, scientists, and students in the field of medicinal chemistry. The book begins by providing a comprehensive overview of cancer biology and the challenges associated with current cancer treatments. It then delves into the role of heterocyclic organic structures in targeting cancer cells and inhibiting their growth. The author discusses the mechanisms of action behind these compounds and highlights their potential as effective anticancer agents. One of the key strengths of this book is its focus on novel drug development. Mchichi L E explores different strategies for designing and synthesizing heterocyclic compounds with enhanced anticancer activity. The book also covers important topics such as structure-activity relationships, pharmacokinetics, and toxicity profiles, providing readers with a well-rounded understanding of the drug development process. In addition to discussing the scientific aspects of anticancer activity in heterocyclic organic structures, the book also addresses practical considerations such as regulatory requirements and intellectual property rights. This makes it a valuable resource for researchers looking to translate their findings into clinical applications. Overall, "Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development" is a must-read for anyone interested in exploring new avenues for cancer treatment. With its comprehensive coverage of both scientific and practical aspects, this book offers valuable insights that can help drive innovation in the field of oncology.
Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development Part 1 by Mchichi L E is a specialized and research-focused book that explores the role of heterocyclic compounds in anticancer drug discovery. Published by Taylor & Francis Group, this 2026 hardbound edition is ideal for researchers, postgraduate students, and professionals in medicinal chemistry and pharmaceutical sciences.
The book provides detailed insights into the design, synthesis, and biological evaluation of heterocyclic organic compounds with anticancer activity. It explains how these structures play a crucial role in developing new and effective cancer therapies.
One of the key highlights of this book is its focus on modern drug development approaches. It covers structure-activity relationships (SAR), molecular mechanisms, and various strategies used to enhance the efficacy and selectivity of anticancer agents.
The content is research-oriented and includes recent advancements, experimental data, and emerging trends in anticancer drug discovery. It helps readers understand the scientific basis behind the development of novel therapeutic agents.
With 184 pages of focused and high-value content, this book serves as a concise yet powerful reference for academic and research purposes. The hardbound format ensures durability, making it suitable for long-term use in laboratories and libraries.
Whether you are involved in medicinal chemistry research or pursuing advanced studies, this book is an essential resource for understanding anticancer drug development using heterocyclic compounds.
| SKU / BOOK Code: | ANTI-CANCER-HETERO-P1-2026-978 |
| Publisher: | Taylor & Francis Group |
| Author: | Mchichi L E |
| Binding Type: | Hardcover |
| No. of Pages: | 184 |
| ISBN-10: | NA |
| ISBN-13: | NA |
| Edition: | 1st |
| Language: | English Medium |
| Publish Year: | 2026-01 |
| Weight (g): | 200 |
| Product Condition: | New |
| Reading Age: | Above 18 Years |
| Country of Origin: | India |
| Genre: | Medicine & Health Sciences |
| Manufacturer: | Taylor & Francis Group |
| Importer: | Taylor & Francis Group |
| Packer: | Fullfilled by Supplier |
"Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development" is a groundbreaking book that explores the potential of heterocyclic organic structures in developing novel drugs for cancer treatment. Authored by Mchichi L E, this latest edition published by Taylor & Francis Group delves into the various aspects of anticancer activity and drug development, making it an essential read for researchers, scientists, and students in the field of medicinal chemistry. The book begins by providing a comprehensive overview of cancer biology and the challenges associated with current cancer treatments. It then delves into the role of heterocyclic organic structures in targeting cancer cells and inhibiting their growth. The author discusses the mechanisms of action behind these compounds and highlights their potential as effective anticancer agents. One of the key strengths of this book is its focus on novel drug development. Mchichi L E explores different strategies for designing and synthesizing heterocyclic compounds with enhanced anticancer activity. The book also covers important topics such as structure-activity relationships, pharmacokinetics, and toxicity profiles, providing readers with a well-rounded understanding of the drug development process. In addition to discussing the scientific aspects of anticancer activity in heterocyclic organic structures, the book also addresses practical considerations such as regulatory requirements and intellectual property rights. This makes it a valuable resource for researchers looking to translate their findings into clinical applications. Overall, "Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development" is a must-read for anyone interested in exploring new avenues for cancer treatment. With its comprehensive coverage of both scientific and practical aspects, this book offers valuable insights that can help drive innovation in the field of oncology.
Anticancer Activity in Heterocyclic Organic Structures: A Pathway to Novel Drug Development Part 1 by Mchichi L E is a specialized and research-focused book that explores the role of heterocyclic compounds in anticancer drug discovery. Published by Taylor & Francis Group, this 2026 hardbound edition is ideal for researchers, postgraduate students, and professionals in medicinal chemistry and pharmaceutical sciences.
The book provides detailed insights into the design, synthesis, and biological evaluation of heterocyclic organic compounds with anticancer activity. It explains how these structures play a crucial role in developing new and effective cancer therapies.
One of the key highlights of this book is its focus on modern drug development approaches. It covers structure-activity relationships (SAR), molecular mechanisms, and various strategies used to enhance the efficacy and selectivity of anticancer agents.
The content is research-oriented and includes recent advancements, experimental data, and emerging trends in anticancer drug discovery. It helps readers understand the scientific basis behind the development of novel therapeutic agents.
With 184 pages of focused and high-value content, this book serves as a concise yet powerful reference for academic and research purposes. The hardbound format ensures durability, making it suitable for long-term use in laboratories and libraries.
Whether you are involved in medicinal chemistry research or pursuing advanced studies, this book is an essential resource for understanding anticancer drug development using heterocyclic compounds.
We practice Easy Return / Exchange / Refund policy for Buyer Protection, So if you experience any difficulties like (Wrong Item delivered) with any of the product received, you can raise request under Return / Exchange Policy through the EXAM360 Customer support Portal i.e. https://support.exam360.in/ with valid details. Once our executive validate the case properly, we will take necessary steps as per the Policy Standard & we will be more than happy to help you to solve your issues ASAP.
While receiving the item from any of our courier partner, users are requested to check the packaging item properly, If you feel the item is delivering by the logistic partners in tampering conditions, we request our buyers not to accept the product & instantly make a call to the below mentioned HELPLINE Numbers. And, If you purchased an item that was not satisfactory, in such cases we will issue Return / Refund as per the current policy guidelines.
Selling Price & Shipping Fee: In Product details page we have clearly mentioned the Selling Price & Shipping Fees separately, So, when you click on "BUY NOW" You will be charges Selling Price + Shipping Fees. The Shipping fees may different for each products depends on the weight of the Product. The shipping cost includes the courier charges, packaging charges, transport charges, fuel charges and other charges. Sometimes the total payable amount may be different for Instamojo Payment Gateway. Buyers are requested to check before purchasing the products. After making the purchase we may not allow or consider users to modify.
- For more information about return policy CLICK HERE
- If you have questions about the product, please contact our dedicated Customer Support Team at ECG Portal.
Generally the courier partner support delivery during business hours (9:00 - 20:00) Mon - Sat: Fedex, Trackon, Gati, Delhivery, Indian Post.
The actual delivery time may differ from the given Estimated timeline. For more information on delivery time and shipping charges, please refer to our dedicated support team through ECG Portal.
Note: Expected Delivery time may differ from the Estimated or Projected delivery time & it does not include holidays.

.png)
.png)
.png)
.png)
.png)
.png)











No comments:
Post a Comment